Other languages Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Real-time Estimate Cboe BZX Other stock markets 12:06:48 2024-05-21 pm EDT			5-day change	1st Jan Change
2.78 ^USD	+0.36%		-2.11%	-31.91%

May. 13	Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating	MT
May. 10	Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Organogenesis Holdings Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024	May. 09
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis	May. 02
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024	Feb. 29
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29
Organogenesis Holdings Insider Sold Shares Worth $940,860, According to a Recent SEC Filing	Jan. 11
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023	Nov. 09
Stocks wilt after early promise with US closed	23-09-04
Hopes of rate peak, China turnaround lift stocks	23-09-04
AIM WINNERS & LOSERS: Physiomics brings in COO; Ergomed receives bid	23-09-04
Advanced Medical issues profit warning following royalty issues	23-09-04
Advanced Medical Solutions Group Updates FY23 Guidance	23-09-04
Top Premarket Decliners	23-08-10
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Organogenesis Holdings Inc. Withdraws Earnings Guidance for the the 2023	23-08-09
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Organogenesis Holdings Inc. Provides Earnings Guidance for the Fiscal Year 2023	23-05-10
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Other languages

Filters